Citation 75437

COLEMAN,JE: DE SILVA,ED: KONG,FM: ANDERSEN,RJ: ALLEN,TM:. (1995). CYTOTOXIC PEPTIDES FROM THE MARINE SPONGE CYMBASTELA SP.. 51(39)

Citation Details

TitleCYTOTOXIC PEPTIDES FROM THE MARINE SPONGE CYMBASTELA SP.
AuthorsCOLEMAN,JE: DE SILVA,ED: KONG,FM: ANDERSEN,RJ: ALLEN,TM:
Year1995
Volume51
Issue39

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (1)

Cymbastela species (AXINELLIDAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
GEODIAMOLIDE G
None
2Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
ASTERLIN A,HEMI:
None
3
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ASTERLIN A,HEMI:
STRONG ACTIVITY
4
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ASTERLIN A,HEMI:
STRONG ACTIVITY
5Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
ASTERLIN B,HEMI:
None
6
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ASTERLIN B,HEMI:
STRONG ACTIVITY
7
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ASTERLIN B,HEMI:
STRONG ACTIVITY
8
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ASTERLIN B,HEMI:
ACTIVE
9Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CRIAMIDE A
None
10Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CRIAMIDE B
None
11
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CRIAMIDE B
ACTIVE
12
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CRIAMIDE B
ACTIVE
13
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CRIAMIDE B
ACTIVE
14
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CRIAMIDE B
STRONG ACTIVITY
15
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CRIAMIDE B
WEAK ACTIVITY
16
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CRIAMIDE B
ACTIVE
17Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
ASTERLIN,HEMI:
None
18
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ASTERLIN,HEMI:
STRONG ACTIVITY
19
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ASTERLIN,HEMI:
STRONG ACTIVITY
20
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ASTERLIN,HEMI:
ACTIVE
21
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ASTERLIN,HEMI:
STRONG ACTIVITY
22
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ASTERLIN,HEMI:
ACTIVE
Show SPARQL Queries (1)